Blonder Tongue Laboratories, Inc. (BDRL)
USD 0.07
(18.24%)
USD 0.07
(18.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.98 Million | -1.38 Million | -1.16 Million | -3.21 Million | -6.53 Million | 587 Thousand |
| Net Income | -2.11 Million | -2.92 Million | 84 Thousand | -7.47 Million | -742 Thousand | -1.33 Million |
| Depreciation & Amortization | 827 Thousand | 891 Thousand | 1.14 Million | 1.1 Million | 1.1 Million | 521 Thousand |
| Deferred income taxes | 78 Thousand | - | 151 Thousand | 287 Thousand | -7.07 Million | -104 Thousand |
| Stock-based compensation | 225 Thousand | 550 Thousand | 725 Thousand | 404 Thousand | 843 Thousand | 493 Thousand |
| Change in working capital | 2.76 Million | -615 Thousand | -1.66 Million | 2.33 Million | -828 Thousand | 836 Thousand |
| Other non-cash items | 214 Thousand | 691 Thousand | -1.43 Million | 137 Thousand | 379 Thousand | 180 Thousand |
| Investing Cash Flow | -647 Thousand | -55 Thousand | -86 Thousand | -191 Thousand | 9.47 Million | -101 Thousand |
| Investments in PPE | -647 Thousand | -55 Thousand | -86 Thousand | -191 Thousand | -316 Thousand | -101 Thousand |
| Acquisitions | - | - | - | - | 9.79 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6000.00 | -7.00 | -55.00 | -26.00 | 9737.00 | -20.00 |
| Financing Cash Flow | -1.41 Million | 1.24 Million | 1.45 Million | 2.9 Million | -2.92 Million | -95 Thousand |
| Debt repayment | -1.41 Million | -745 Thousand | -61 Thousand | -594 Thousand | -5.63 Million | -251 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 492 Thousand | 812 Thousand | 137 Thousand | 16 Thousand |
| Other Financing Activities | - | 1.98 Million | 1.02 Million | 2.68 Million | 2.57 Million | 140 Thousand |
| Accounts receivables | 1.85 Million | -1.6 Million | 11 Thousand | 516 Thousand | 175 Thousand | -33 Thousand |
| Accounts payables | -389 Thousand | 1.05 Million | 456 Thousand | -2.33 Million | 2.29 Million | 1.37 Million |
| Inventory | 1.19 Million | 543 Thousand | -791 Thousand | 4.42 Million | -1.76 Million | -312 Thousand |
| Other working capital | 108 Thousand | -617 Thousand | -1.34 Million | -271 Thousand | -1.54 Million | -195 Thousand |
| Cash at beginning of period | 79 Thousand | 274 Thousand | 69 Thousand | 572 Thousand | 559 Thousand | 168 Thousand |
| Cash at end of period | 8000.00 | 79 Thousand | 274 Thousand | 69 Thousand | 572 Thousand | 559 Thousand |
| Capital Expenditure | -647 Thousand | -55 Thousand | -86 Thousand | -191 Thousand | -316 Thousand | -101 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -486 Thousand |
| Net cash flow / Change in cash | -71 Thousand | -195 Thousand | 205 Thousand | -503 Thousand | 13 Thousand | 391 Thousand |
| Free Cash Flow | 1.34 Million | -1.43 Million | -1.25 Million | -3.4 Million | -6.85 Million | 486 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -98 Thousand | -240 Thousand | -2.11 Million | -547 Thousand | -338 Thousand | -715 Thousand |
| Depreciation & Amortization | 225 Thousand | 222 Thousand | 827 Thousand | 216 Thousand | 215 Thousand | 210 Thousand |
| Deferred income taxes | - | - | 78 Thousand | 124 Thousand | - | -31 Thousand |
| Stock-based compensation | 2000.00 | 11 Thousand | 225 Thousand | 67 Thousand | 42 Thousand | 47 Thousand |
| Change in working capital | 490 Thousand | 367 Thousand | 2.76 Million | 978 Thousand | 42 Thousand | 1.03 Million |
| Other non-cash items | 55 Thousand | 53 Thousand | 214 Thousand | 29 Thousand | 53 Thousand | 55 Thousand |
| Investing Cash Flow | -5000.00 | -4000.00 | -647 Thousand | -645 Thousand | -6000.00 | 1000.00 |
| Investments in PPE | -5000.00 | -4000.00 | -647 Thousand | -641 Thousand | -6000.00 | - |
| Acquisitions | - | - | - | -4000.00 | - | 1000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5000.00 | - | - | - | - | - |
| Financing Cash Flow | -621 Thousand | -95 Thousand | -1.41 Million | -331 Thousand | 10 Thousand | -698 Thousand |
| Debt repayment | -621 Thousand | -95 Thousand | -1.41 Million | -331 Thousand | -10 Thousand | -698 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 20 Thousand | - |
| Accounts receivables | -78 Thousand | -4000.00 | 1.85 Million | 37 Thousand | -147 Thousand | 771 Thousand |
| Accounts payables | -28 Thousand | 601 Thousand | -389 Thousand | -259 Thousand | - | -167 Thousand |
| Inventory | 325 Thousand | 41 Thousand | 1.19 Million | 168 Thousand | 385 Thousand | 384 Thousand |
| Other working capital | 279 Thousand | -271 Thousand | 108 Thousand | 1.03 Million | -196 Thousand | 46 Thousand |
| Cash at beginning of period | 36 Thousand | 8000.00 | 79 Thousand | 117 Thousand | 99 Thousand | 196 Thousand |
| Cash at end of period | 71 Thousand | 36 Thousand | 8000.00 | 8000.00 | 117 Thousand | 99 Thousand |
| Capital Expenditure | -5000.00 | -4000.00 | -647 Thousand | -641 Thousand | -6000.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 35 Thousand | 28 Thousand | -71 Thousand | -109 Thousand | 18 Thousand | -97 Thousand |
| Free Cash Flow | 656 Thousand | 123 Thousand | 1.34 Million | 226 Thousand | 8000.00 | 600 Thousand |
CAF
003035
MNDR
3088
SPLM
GODREJIND